Last update 03 Apr 2025

Pulmonary Arterial Hypertension Treatment (AliveGen)

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
selective ligand trap in the form of a heavy chain fragment fusion protein consisting of a modified extracellular domain of the human Activin Type 2B Receptor fused to a stabilized human immunoglobulin G4 (IgG4) Fc
Target
ACVR2B
Action
agonists
Mechanism
ACVR2B agonists(Activin receptor type-2B agonists)
Therapeutic Areas
Respiratory DiseasesOther Diseases
Active Indication
Pulmonary Arterial Hypertension
Inactive Indication-
Originator Organization-
Active Organization
AliveGen USA, Inc.AliveGen USA, Inc.Startup
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
RegulationOrphan Drug (United States)

Related

100 Clinical Results associated with Pulmonary Arterial Hypertension Treatment (AliveGen)
Login to view more data
100 Translational Medicine associated with Pulmonary Arterial Hypertension Treatment (AliveGen)
Login to view more data
100 Patents (Medical) associated with Pulmonary Arterial Hypertension Treatment (AliveGen)
Login to view more data
100 Deals associated with Pulmonary Arterial Hypertension Treatment (AliveGen)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pulmonary Arterial HypertensionPreclinical
United States
AliveGen USA, Inc.AliveGen USA, Inc.Startup
18 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free